NEW YORK, Sept. 23, 2022 /PRNewswire/ — Jakubowitz Legislation broadcasts {that a} securities fraud class motion lawsuit has commenced on behalf of shareholders of Co-Diagnostics, Inc. (NASDAQ: CODX).
To obtain updates on the lawsuit, fill out the shape:
https://claimyourloss.com/securities/co-diagnostics-inc-loss-submission-form-2/?id=32058&from=4
This lawsuit is on behalf of a category of all individuals and entities who bought the publicly traded securities of Co-Dx throughout the interval of Could 12, 2022 by way of the shut of the market on August 11, 2022 (4:00 pm ET).
Shareholders considering appearing as a lead plaintiff representing the category of wronged shareholders have till October 17, 2022 to petition the courtroom. Your means to share in any restoration would not require that you just function a lead plaintiff.
In accordance with a filed grievance, Co-Diagnostics, Inc. issued materially false and/or deceptive statements and/or didn’t disclose that: (i) demand for the Firm’s Logix Sensibleā¢ COVID-19 check had plummeted all through the quarter ended June 30, 2022and (ii) in consequence, the defendants’ constructive statements concerning the demand for its Logix Sensibleā¢ COVID-19 check lacked an inexpensive foundation.
Jakubowitz Legislation is vigorous within the pursuit of justice for shareholders who’ve been the sufferer of securities fraud. Legal professional promoting. Prior outcomes don’t assure related outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
ninth Flooring
New York, New York 10036
Q: (212) 867-4490
F: (212) 537-5887
View unique content material:https://www.prnewswire.com/news-releases/codx-shareholder-alert-jakubowitz-law-reminds-co-dx-shareholders-of-a-lead-plaintiff-deadline-of-october- 17-2022-301631319.html
SOURCE Jakubowitz Legislation